Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis

Meta Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Review for "Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis"

10.1111/dom.13989/v1/review2 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Decision letter for "Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis"

10.1111/dom.13989/v1/decision1 ◽

2019 ◽

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Review for "Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis"

10.1111/dom.13989/v2/review1 ◽

2020 ◽

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Author response for "Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis"

10.1111/dom.13989/v2/response1 ◽

2020 ◽

Author(s):

Niki Katsiki ◽

Richard Ofori‐Asenso ◽

Ele Ferrannini ◽

Mohsen Mazidi

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Fixed Dose Combination ◽

Author Response ◽

Fixed Dose ◽

Decision letter for "Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis"

10.1111/dom.13989/v2/decision1 ◽

2020 ◽

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Review for "Fixed‐dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta‐analysis"

10.1111/dom.13989/v1/review1 ◽

2019 ◽

Author(s):

BINAYAK SINHA

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Network Meta-Analysis To Assess The Relative Efficacy And Safety of Linagliptin, Empagliflozin And The Fixed Dose Combination of Empagliflozin And Linagliptin In Patients With Type 2 Diabetes Mellitus (T2DM)

Value in Health ◽

10.1016/j.jval.2016.09.1844 ◽

2016 ◽

Vol 19 (7) ◽

pp. A667

Author(s):

I Daacke ◽

S Kanters ◽

K Thorlund ◽

A Tebboth

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Relative Efficacy ◽

Efficacy And Safety ◽

The hypolipidemic and hepatoprotective efficacies of a fixed-dose combination of essential phospholipids with methionine (EPL+M) during atorvastatin (A) therapy in hyperlipidemic patients with cardiovascular diseases (CVD) and type 2 diabetes mellitus (DM) (OLYMP trial)

Endocrine Abstracts ◽

10.1530/endoabs.49.ep598 ◽

2017 ◽

Author(s):

M G Bubnova ◽

D M Aronov ◽

Marina Bubnoa ◽

David Aronov

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Diseases ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Essential Phospholipids

135-OR: The Effect of Fixed-Dose Combination of Insulin Degludec and Liraglutide on Serum Lipoprotein Metabolism in Patients with Type 2 Diabetes Mellitus

Diabetes ◽

10.2337/db20-135-or ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 135-OR

Author(s):

ELENI PAPPA ◽

CHRISTINA KOSTARA ◽

CONSTANTINOS TELLIS ◽

ALEXANDROS D. TSELEPIS ◽

ELENI BAIRAKTARI ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Lipoprotein Metabolism ◽

Serum Lipoprotein ◽

Insulin Degludec ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus

Expert Opinion on Pharmacotherapy ◽

10.1517/14656566.2013.770839 ◽

2013 ◽

Vol 14 (4) ◽

pp. 361-370 ◽

Cited By ~ 12

Author(s):

Yuri Ono ◽

Hiraku Kameda ◽

Kyu Yong Cho

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Fixed Dose Combination ◽

Fixed Dose ◽